Keywords: Antibiotic drug resistance; Caenorhabditis elegans; Methicillin-resistant Staphylococcus aureus; MRSA; Intracellular infection; Pharmacokinetics; AMR; Antimicrobial resistance; Caco-2; heterogeneous human epithelial colorectal adenocarcinoma cells; CFUs;